5 Growth Stocks with Upside Potential

Page 5 of 5

1. ImmunoGen, Inc. (NASDAQ:IMGN)

Number of Hedge Fund Holders: 31

Stock performance over the past six months through November 25: +50%

ImmunoGen, Inc. (NASDAQ:IMGN) is a clinical-stage biotech firm. In late March, the company submitted a request for the accelerated approval of mirvetuximab soravtansine, a therapy for the treatment of patients with resistant ovarian cancer who have previously received treatments. The stock has gained after the company signed a deal with drug giant Eli Lilly for the development and commercialization of antibody-drug conjugates. The drugs will be based on the camptothecin platform of the firm. 

ImmunoGen, Inc. (NASDAQ:IMGN) has a growth plan that involves licensing technologies to other companies and then investing the revenue generated from the sale to a dedicated pipeline of smart medicines. One of the premier pipeline drugs is mirvetuximab. 

At the end of the fourth quarter of 2021, 31 hedge funds in the database of Insider Monkey held stakes worth $502 million in ImmunoGen, Inc. (NASDAQ:IMGN), up from 26 in the preceding quarter worth $362 million. 

You can also take a peek at 10 Best Stocks for Animal Lovers and 10 Best Nickel Stocks to Buy Now.

Page 5 of 5